Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001078

SVP, Chief Medical Officer acquired 1,714 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Meyers Michael L. · SVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Other acquisition : show line 1 in the form +1,714 $12.39 $21,236 23,280 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-02 Grant or award : show line 2 in the form Stock Options (Right to buy) +17,350 $15.79 $273,957 17,350 D
Loading xslF345X03/primarydocument.xml…